Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy

The retained functionality of the sodium iodide symporter (NIS) expressed in differentiated thyroid cancer (DTC) cells allows the further utilization of post-surgical radioactive iodine (RAI) therapy, which is an effective treatment for reducing the risk of recurrence, and even the mortality, of DTC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jierui, Liu, Yanqing, Lin, Yansong, Liang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769341/
https://www.ncbi.nlm.nih.gov/pubmed/31565873
http://dx.doi.org/10.3803/EnM.2019.34.3.215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769341/
https://www.ncbi.nlm.nih.gov/pubmed/31565873
http://dx.doi.org/10.3803/EnM.2019.34.3.215

Ejemplares similares